ATE279192T1 - Die verwendung eines benzimidazoles zur herstellung eines medikamentes zur krebsvorbeugung - Google Patents
Die verwendung eines benzimidazoles zur herstellung eines medikamentes zur krebsvorbeugungInfo
- Publication number
- ATE279192T1 ATE279192T1 AT00952534T AT00952534T ATE279192T1 AT E279192 T1 ATE279192 T1 AT E279192T1 AT 00952534 T AT00952534 T AT 00952534T AT 00952534 T AT00952534 T AT 00952534T AT E279192 T1 ATE279192 T1 AT E279192T1
- Authority
- AT
- Austria
- Prior art keywords
- sub
- carbon atoms
- less
- hydrogen
- benzimidazole
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title abstract 3
- 201000011510 cancer Diseases 0.000 title abstract 3
- HYZJCKYKOHLVJF-UHFFFAOYSA-N 1H-benzimidazole Chemical compound C1=CC=C2NC=NC2=C1 HYZJCKYKOHLVJF-UHFFFAOYSA-N 0.000 title abstract 2
- 239000003814 drug Substances 0.000 title abstract 2
- 229940079593 drug Drugs 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 5
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 3
- 230000002401 inhibitory effect Effects 0.000 abstract 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical group [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 229910052801 chlorine Inorganic materials 0.000 abstract 1
- 239000000460 chlorine Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical group 0.000 abstract 1
- -1 nitro, methyl Chemical group 0.000 abstract 1
- 125000005430 oxychloro group Chemical group 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 229940124597 therapeutic agent Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/374,717 US6423734B1 (en) | 1999-08-13 | 1999-08-13 | Method of preventing cancer |
| PCT/US2000/021381 WO2001012169A2 (en) | 1999-08-13 | 2000-08-04 | Method of cancer treatment |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE279192T1 true ATE279192T1 (de) | 2004-10-15 |
Family
ID=23477934
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00952534T ATE279192T1 (de) | 1999-08-13 | 2000-08-04 | Die verwendung eines benzimidazoles zur herstellung eines medikamentes zur krebsvorbeugung |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US6423734B1 (de) |
| EP (1) | EP1202735B1 (de) |
| JP (1) | JP2003506482A (de) |
| AT (1) | ATE279192T1 (de) |
| AU (1) | AU763311B2 (de) |
| CA (1) | CA2380414C (de) |
| CO (1) | CO5200778A1 (de) |
| DE (1) | DE60014916T2 (de) |
| MX (1) | MXPA02001571A (de) |
| NZ (1) | NZ516766A (de) |
| PE (1) | PE20010541A1 (de) |
| WO (1) | WO2001012169A2 (de) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6479526B1 (en) | 1995-04-12 | 2002-11-12 | The Procter & Gamble Company | Pharmaceutical composition for inhibiting the growth of viruses and cancers |
| US6506783B1 (en) * | 1997-05-16 | 2003-01-14 | The Procter & Gamble Company | Cancer treatments and pharmaceutical compositions therefor |
| US6423734B1 (en) * | 1999-08-13 | 2002-07-23 | The Procter & Gamble Company | Method of preventing cancer |
| DE60115069T2 (de) | 2000-09-11 | 2006-08-03 | Chiron Corp., Emeryville | Chinolinonderivate als tyrosin-kinase inhibitoren |
| US6462062B1 (en) * | 2000-09-26 | 2002-10-08 | The Procter & Gamble Company | Compounds and methods for use thereof in the treatment of cancer or viral infections |
| US6608096B1 (en) * | 2000-09-26 | 2003-08-19 | University Of Arizona Foundation | Compounds and methods for use thereof in the treatment of cancer or viral infections |
| US6380232B1 (en) | 2000-09-26 | 2002-04-30 | The Procter & Gamble Company | Benzimidazole urea derivatives, and pharmaceutical compositions and unit dosages thereof |
| AU2002239395A1 (en) * | 2000-11-01 | 2002-06-03 | The Procter And Gamble Company | Hiv treatment with benzimidazoles |
| CZ20032691A3 (en) | 2001-03-12 | 2004-04-14 | Avanir Pharmaceuticals | Benzimidazole compounds for modulating ige and inhibiting cellular proliferation |
| US20050038022A1 (en) * | 2001-03-26 | 2005-02-17 | Unisearch Limited | Method for treatment of cancer and compositions for use therein |
| AU2002245927B2 (en) * | 2001-03-26 | 2005-11-17 | Pitney Pharmaceuticals Pty Limited | Method for treatment of cancer and compositions for use therein |
| US20030158118A1 (en) * | 2001-11-26 | 2003-08-21 | Weidner Morten Sloth | Combination of cimetidine and cysteine derivatives for treating cancer |
| AU2003220585A1 (en) * | 2002-03-26 | 2003-10-13 | Arizona Board of Regents on behalf of the University of Arizone | Solubilization of weak bases |
| EP1539754A4 (de) | 2002-08-23 | 2009-02-25 | Novartis Vaccines & Diagnostic | Benzimidazolchinolinone und deren verwendung |
| WO2004024655A2 (en) | 2002-09-12 | 2004-03-25 | Avanir Pharmaceuticals | Phenyl-indole compounds for modulating ige and inhibiting cellular proliferation |
| TWI276631B (en) | 2002-09-12 | 2007-03-21 | Avanir Pharmaceuticals | Phenyl-aza-benzimidazole compounds for modulating IgE and inhibiting cellular proliferation |
| MXPA05009564A (es) * | 2003-03-12 | 2005-11-17 | Univ Arizona | Sales de bases debiles. |
| US20090286838A1 (en) * | 2004-12-06 | 2009-11-19 | Newsouth Innovations Pty Limited | Treatment for cancer |
| US20060257317A1 (en) * | 2005-05-04 | 2006-11-16 | Duke University | Combination therapy in the treatment of cancer |
| EP2465857B1 (de) | 2005-05-17 | 2014-06-04 | Novartis AG | Verfahren zum Synthetisieren heterocyclischer Verbindungen |
| EP2432451A2 (de) * | 2009-05-20 | 2012-03-28 | Children's Medical Center Corporation | Zusammensetzungen für die behandlung von metastasierendem krebs und anwendungsverfahren dafür |
Family Cites Families (85)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2933502A (en) | 1958-02-12 | 1960-04-19 | Du Pont | Benzimidazolone derivatives |
| US3010968A (en) | 1959-11-25 | 1961-11-28 | Du Pont | Process for manufacture of certain alkyl esters of benzimidazole carbamic acids |
| NL134354C (de) | 1963-05-23 | |||
| US3499761A (en) | 1964-07-20 | 1970-03-10 | Gaf Corp | Silver halide emulsions containing alkyl esters of benzimidazole carbamic acid antifogging agents |
| BE666795A (de) * | 1964-08-04 | 1966-01-13 | ||
| USRE28403E (en) | 1964-08-04 | 1975-04-29 | Butyl and n-propoxy-z-carbo- methoxyaminobenzimidazoles | |
| US3541213A (en) | 1966-05-06 | 1970-11-17 | Du Pont | Fungicidal and mite ovicidal substituted 2-aminobenzimidazoles |
| US3399212A (en) | 1966-05-16 | 1968-08-27 | Smith Kline French Lab | Benzimidazole ureas |
| US3480642A (en) | 1967-03-22 | 1969-11-25 | Smithkline Corp | Process for producing 2-carbalkoxyaminobenzimidazoles |
| US3881014A (en) | 1968-11-05 | 1975-04-29 | Bayer Ag | N-tritylimidazoles for treating fungal infections |
| BE744970A (fr) | 1969-01-28 | 1970-07-27 | Lilly Co Eli | Agents antiviraux et immuno-depresseurs |
| BE759337A (fr) | 1969-11-24 | 1971-05-24 | Lilly Co Eli | Benzimidazol (2,1-b)-quinazolin (6h) ones qui sont des immuno-depresseurs, et nouvelles benzimidazo (2,1-b) quinazolin-12-(6h) ones |
| FR2046114A5 (en) | 1970-01-30 | 1971-03-05 | Dynachim Sarl | Benzimidazole derivs anthelmintic, antifung - al bactericidal, aericidal, insecticidal, nema |
| US3956262A (en) | 1970-12-09 | 1976-05-11 | Beecham Group Limited | Triazenoimidazoles |
| US3738995A (en) | 1971-05-14 | 1973-06-12 | Du Pont | Solvent process for the preparation of 1 - carbamoyl-substituted 2 - benzimidazolecarbamates |
| DE2144505A1 (de) | 1971-09-06 | 1973-03-15 | Boehringer Sohn Ingelheim | S-triazino- eckige klammer auf 1,2-a eckige klammer zu-benzimidazole |
| FR2155888A1 (en) | 1971-10-13 | 1973-05-25 | Agot Aime | Solid anthelmintic composn - for more economical treatment of ruminants |
| DE2227919C2 (de) | 1972-06-08 | 1982-12-23 | Bayer Ag, 5090 Leverkusen | Verfahren zur Herstellung von Benzimidazol-2-yl-carbaminsäure-methylester |
| DE2253324A1 (de) | 1972-10-31 | 1974-05-09 | Bayer Ag | 1-alkoxycarbonyl-2- eckige klammer auf bis-(alkoxycarbonyl)-amino eckige klammer zu -benzimidazole, verfahren zu ihrer herstellung, sowie ihre verwendung als fungizide |
| US4046906A (en) | 1973-04-21 | 1977-09-06 | Hoechst Aktiengesellschaft | Salts of alkyl 2-benzimidazole-carbamate |
| JPS5134161A (en) | 1974-09-18 | 1976-03-23 | Yoshitomi Pharmaceutical | 22 benzuimidazoorukarubaminsanesuteru no seizoho |
| JPS5142565A (en) | 1974-10-09 | 1976-04-10 | Copal Co Ltd | onnoff taimaa |
| US4001423A (en) | 1975-06-20 | 1977-01-04 | Dodds Dale I | 2-(2-ethoxy)ethoxyethyl benzimidazolecarbamate |
| DE2527677A1 (de) | 1975-06-21 | 1977-01-20 | Bayer Ag | Verfahren zur herstellung von 2,4- dioxo-1,2,3,4-tetrahydro-s-triazino- eckige klammer auf 1,2-a eckige klammer zu -benzimidazolen |
| US4086235A (en) | 1976-04-12 | 1978-04-25 | Syntex (U.S.A.) Inc. | 5 (6)-Benzene ring substituted benzimidazole-2-carbamate derivatives having anthelmintic activity |
| IN159210B (de) | 1982-01-11 | 1987-04-11 | Council Scient Ind Res | |
| IN158878B (de) | 1982-07-15 | 1987-02-07 | Council Scient Ind Res | |
| HU193951B (en) | 1985-03-11 | 1987-12-28 | Richter Gedeon Vegyeszet | Process for producing new sulfur-containing 5-substituted benzimidazol derivatives and pharmaceutical compositions containing them |
| JPS6323274A (ja) | 1986-07-16 | 1988-01-30 | Sony Corp | デ−タ伝送方法 |
| US4731366A (en) | 1986-08-05 | 1988-03-15 | Harbor Branch Oceanographic Institution, Inc. | Discorhabdin compositions and their methods of use |
| GB2210875B (en) | 1987-10-09 | 1991-05-29 | Farmos Oy | Aromatase inhibiting 4(5)-imidazoles |
| US5329012A (en) | 1987-10-29 | 1994-07-12 | The Research Foundation Of State University Of New York | Bis(acyloxmethyl)imidazole compounds |
| US5114951A (en) | 1989-04-11 | 1992-05-19 | Burroughs Wellcome Company | Agents for combating multiple drug resistance |
| US5149527A (en) | 1990-09-18 | 1992-09-22 | Oncotech, Inc. | Immunopotentiating protocol for chemotherapy-responsive tumors |
| US5284662A (en) | 1990-10-01 | 1994-02-08 | Ciba-Geigy Corp. | Oral osmotic system for slightly soluble active agents |
| GB9106278D0 (en) | 1991-03-25 | 1991-05-08 | Smithkline Beecham Plc | Method of treatment |
| US5364875A (en) | 1992-05-11 | 1994-11-15 | The Du Pont Merck Pharmaceutical Company | Imidazoles linked to bicyclic heterocyclic groups for the treatment of atherosclerosis |
| US5310748A (en) | 1992-05-11 | 1994-05-10 | The Du Pont Merck Pharmaceutical Company | Imidazoles for the treatment of atherosclerosis |
| US5290801A (en) | 1992-05-29 | 1994-03-01 | The Du Pont Merck Pharmaceutical Company | Benzimidazoles for the treatment of atherosclerosis |
| CA2140653A1 (en) | 1992-08-12 | 1994-03-03 | Irene Abraham | Protein kinase inhibitors and related compounds combined with taxol |
| FR2703057B1 (fr) | 1993-03-24 | 1995-06-16 | Elysees Balzac Financiere | Matériau alvéolaire cellulosique renfermant un agent biocide et procédé pour sa préparation. |
| RO118000B1 (ro) | 1993-03-31 | 2002-12-30 | Merck & Co Inc | Metoda pentru tratamentul sida, prevenirea si tratamentul infectiei cu hiv sau inhibarea proteazei hiv si compozitie farmaceutica pentru aplicarea metodei |
| US5434163A (en) | 1993-05-14 | 1995-07-18 | The Medical College Of Pennsylvania | Treatment of Cryptococcus neoformans infection |
| US5554373A (en) | 1993-11-05 | 1996-09-10 | Seabrook; Samuel G. | Compositions containing anti-microbial agents and methods for making and using same |
| JP3213471B2 (ja) | 1994-04-13 | 2001-10-02 | ポーラ化成工業株式会社 | 薬効成分含有リポソーム製剤の製造方法 |
| NZ305784A (en) | 1995-04-12 | 2001-03-30 | Procter & Gamble | Benzimidazole containing medicaments for treating cancers, tumors and viral infections |
| US5656615A (en) | 1995-04-12 | 1997-08-12 | The Procter & Gamble Company | Pharmaceutical composition for inhibiting the growth of cancers and viruses in mammals |
| ZA962880B (en) | 1995-04-12 | 1997-03-17 | Procter & Gamble | A pharmaceutical composition for inhibiting the growth of viruses and cancers |
| US6262093B1 (en) * | 1995-04-12 | 2001-07-17 | The Proctor & Gamble Company | Methods of treating cancer with benzimidazoles |
| ZA962879B (en) * | 1995-04-12 | 1997-03-17 | Procter & Gamble | A pharmaceutical composition for inhibiting the growth of viruses and cancers |
| US6177460B1 (en) * | 1995-04-12 | 2001-01-23 | The Procter & Gamble Company | Method of treatment for cancer or viral infections |
| AU714056B2 (en) * | 1995-04-12 | 1999-12-16 | Uaf Technologies And Research Llc | A pharmaceutical composition containing N-chlorophenylcarbamates and N-chlorophenylthiocarbamates for inhibiting the growth of viruses and cancers |
| US5665713A (en) | 1995-04-12 | 1997-09-09 | Procter & Gamble Company | Pharmaceutical composition for inhibiting the growth of viruses and cancers |
| US5629341A (en) | 1995-04-12 | 1997-05-13 | The Procter & Gamble Company | Pharmaceutical composition for inhibiting the growth of viruses and cancers |
| US5665751A (en) | 1995-06-07 | 1997-09-09 | The Procter & Gamble Company | Pharmaceutical composition for inhibiting the growth of cancers |
| MX9707809A (es) | 1995-06-07 | 1998-01-31 | Procter & Gamble | Una composicion farmaceutica que contiene bencimidazol para inhibir el crecimiento de canceres. |
| US5770616A (en) * | 1995-06-07 | 1998-06-23 | The Procter & Gamble Company | Pharmaceutical composition for inhibiting the growth of cancers |
| US20010039291A1 (en) * | 1995-06-07 | 2001-11-08 | The Procter & Gamble Company | Compositions and methods of treatment for cancer or viral infections |
| US6265427B1 (en) * | 1995-06-07 | 2001-07-24 | The Proctor & Gamble Company | Pharmaceutical composition for the method of treating leukemia |
| CN1186433A (zh) | 1995-06-07 | 1998-07-01 | 普罗克特和甘保尔公司 | 苯并咪唑类在制备白血病治疗药物上的应用 |
| US6200992B1 (en) * | 1995-06-07 | 2001-03-13 | The Procter & Gamble Company | Pharmaceutical composition for inhibiting the growth of cancers |
| KR19990036137A (ko) | 1995-08-03 | 1999-05-25 | 데이비드 엠 모이어 | 암 성장을 억제하기 위한 그리세오풀빈의 용도 |
| MX9707808A (es) * | 1995-08-04 | 1998-01-31 | Procter & Gamble | Una composicion farmaceutica que contiene n-clorofenilcarbamatos y n-clorofiniltiocarbamatos para inhibir el crecimiento de virus y canceres. |
| US6686391B2 (en) * | 1995-08-04 | 2004-02-03 | University Of Arizona Foundation | N-chlorophenylcarbamate and N-chlorophenylthiocarbamate compositions |
| US5908855A (en) | 1996-07-16 | 1999-06-01 | The Procter & Gamble Company | Compositions for treating viral infections |
| EP0841921A2 (de) | 1995-08-04 | 1998-05-20 | The Procter & Gamble Company | Verwendung von fluoconazol zur hemmung des krebswachtums |
| AU6966696A (en) | 1995-10-05 | 1997-04-28 | Warner-Lambert Company | Method for treating and preventing inflammation and atherosclerosis |
| US5900429A (en) * | 1997-01-28 | 1999-05-04 | The Procter & Gamble Company | Method for inhibiting the growth of cancers |
| PE11499A1 (es) | 1997-05-16 | 1999-03-01 | Procter & Gamble | Tratamiento del hiv y cancer |
| US6506783B1 (en) | 1997-05-16 | 2003-01-14 | The Procter & Gamble Company | Cancer treatments and pharmaceutical compositions therefor |
| US6245789B1 (en) | 1998-05-19 | 2001-06-12 | The Procter & Gamble Company | HIV and viral treatment |
| ATE429813T1 (de) | 1998-10-09 | 2009-05-15 | Gen Mills Inc | Verkapselung empfindlicher flüssiger komponenten in eine matrix zur gewinnung diskreter lagerbeständiger partikel |
| US6211177B1 (en) | 1998-11-24 | 2001-04-03 | Cell Pathways, Inc. | Method for treating neoplasia by exposure to substituted 2-aryl-benzimidazole derivatives |
| US20010053773A1 (en) * | 1998-12-22 | 2001-12-20 | The Procter & Gamble Company | Method for inhibiting the growth of cancers |
| US6294192B1 (en) | 1999-02-26 | 2001-09-25 | Lipocine, Inc. | Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents |
| US6136835A (en) * | 1999-05-17 | 2000-10-24 | The Procter & Gamble Company | Methods of treatment for viral infections |
| US6423734B1 (en) | 1999-08-13 | 2002-07-23 | The Procter & Gamble Company | Method of preventing cancer |
| US20010047021A1 (en) | 2000-04-28 | 2001-11-29 | The Procter & Gamble Company | Cancer treatment |
| US6384049B1 (en) * | 2000-05-25 | 2002-05-07 | The Procter & Gamble Company | Cancer treatment |
| US6290929B1 (en) * | 2000-07-28 | 2001-09-18 | The Procter & Gamble Company | Cancer treatment |
| US6518269B1 (en) | 2000-07-28 | 2003-02-11 | University Of Arizona Foundation | Cancer treatment |
| US6407105B1 (en) * | 2000-09-26 | 2002-06-18 | The Procter & Gamble Company | Compounds and methods for use thereof in the treatment of cancer or viral infections |
| AU2001292796B2 (en) | 2000-09-26 | 2005-12-22 | Uaf Technologies And Research Llc | Benzimidazoles and methods for use thereof in the treatment of cancer or viral infections |
| US6380232B1 (en) * | 2000-09-26 | 2002-04-30 | The Procter & Gamble Company | Benzimidazole urea derivatives, and pharmaceutical compositions and unit dosages thereof |
| AU2002239395A1 (en) | 2000-11-01 | 2002-06-03 | The Procter And Gamble Company | Hiv treatment with benzimidazoles |
-
1999
- 1999-08-13 US US09/374,717 patent/US6423734B1/en not_active Expired - Fee Related
-
2000
- 2000-08-04 DE DE60014916T patent/DE60014916T2/de not_active Expired - Fee Related
- 2000-08-04 AT AT00952534T patent/ATE279192T1/de not_active IP Right Cessation
- 2000-08-04 WO PCT/US2000/021381 patent/WO2001012169A2/en not_active Ceased
- 2000-08-04 EP EP00952534A patent/EP1202735B1/de not_active Expired - Lifetime
- 2000-08-04 JP JP2001516515A patent/JP2003506482A/ja active Pending
- 2000-08-04 NZ NZ516766A patent/NZ516766A/en unknown
- 2000-08-04 AU AU65210/00A patent/AU763311B2/en not_active Ceased
- 2000-08-04 MX MXPA02001571A patent/MXPA02001571A/es active IP Right Grant
- 2000-08-04 CA CA002380414A patent/CA2380414C/en not_active Expired - Fee Related
- 2000-08-09 PE PE2000000809A patent/PE20010541A1/es not_active Application Discontinuation
- 2000-08-11 CO CO00060242A patent/CO5200778A1/es not_active Application Discontinuation
-
2002
- 2002-07-18 US US10/198,334 patent/US6906091B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| DE60014916T2 (de) | 2005-04-07 |
| US6906091B2 (en) | 2005-06-14 |
| US6423734B1 (en) | 2002-07-23 |
| EP1202735A2 (de) | 2002-05-08 |
| AU6521000A (en) | 2001-03-13 |
| CA2380414C (en) | 2006-06-13 |
| AU763311B2 (en) | 2003-07-17 |
| CA2380414A1 (en) | 2001-02-22 |
| EP1202735B1 (de) | 2004-10-13 |
| JP2003506482A (ja) | 2003-02-18 |
| PE20010541A1 (es) | 2001-05-16 |
| DE60014916D1 (de) | 2004-11-18 |
| NZ516766A (en) | 2003-11-28 |
| US20030032664A1 (en) | 2003-02-13 |
| WO2001012169A2 (en) | 2001-02-22 |
| MXPA02001571A (es) | 2003-10-14 |
| WO2001012169A3 (en) | 2002-02-14 |
| CO5200778A1 (es) | 2002-09-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE279192T1 (de) | Die verwendung eines benzimidazoles zur herstellung eines medikamentes zur krebsvorbeugung | |
| CY1107850T1 (el) | Παραγωγα θειαδιαζολυλοπιπεραζiνης mε χρησιμοτητα στην αποτροπη ή στην αγωγη εναντι tου αλγους | |
| PL1697370T3 (pl) | Azabicykliczne heterocykle jako modulatory receptora kanabinoidowego | |
| UY25679A1 (es) | Derivados de quinolin-2-ona inhibidores de la farnesil proteína transferasa útiles como agentes contra el cáncer | |
| MX2008010187A (es) | Tratamiento de distrofia muscular de duchenne. | |
| PL1697371T3 (pl) | Azabicykliczne heterocykle jako modulatory receptora kanabinoidowego | |
| ATE242634T1 (de) | Benzimidazolderivaten-enthaltende pharmazeutische zusammensetzungen zur inhibierung des krebswachstums | |
| DE602004011394D1 (en) | Thiazolderivate | |
| NO20055655L (no) | Anvendelse av azetidinkarboksamidderivater i terapi | |
| RU94044454A (ru) | Ингибитор аутоимунных заболеваний | |
| NO20004162D0 (no) | Antitumor agens | |
| IL195016A0 (en) | 1h-indol-5-yl-piperazin-1-yl-methanone derivatives | |
| TW200716547A (en) | Piperidin-4-yl-amide derivatives | |
| TW200602035A (en) | [4-(5-Aminomethyl-2-fluoro-phenyl)-piperidin-1-yl]-(4-bromo-3-methyl-5-propoxy-thiophen-2-yl)-methanone hydrochloride as an inhibitor of mast cell tryptase | |
| NO975660L (no) | Anvendelse av benzimidazoler for fremstilling av et medikament for behandling av leukemi | |
| RU94045271A (ru) | Применение 2-фенил-3-ароилбензотиофенов для ингибирования синдрома тернера | |
| IL160082A0 (en) | Quinoline derivatives and use thereof as antitumor agents | |
| NO20020804D0 (no) | Nye A-500359-derivater | |
| EA200600022A1 (ru) | Применение производных бицикло [2.2.1] гептана для приготовления нейропротекторных фармацевтических композиций | |
| RU94044323A (ru) | Средство ингибирования навязчиво-компульсивных состояний и расстройств потребления | |
| MXPA06000651A (es) | Uso de derivados de indazol para el tratamiento de dolor neuropatico. | |
| MX9709833A (es) | Uso de benzimidazoles para la fabricacion de un medicamento para el tratamiento de leucemia. | |
| EE200100193A (et) | 3-(1H-imidasool-4-ülmetüül)-indaan-5-ol'i kasutamine intraspinaalselt, teekasiseselt või epiduraalselt manustatava ravimi tootmises | |
| AR011136A1 (es) | Compuesto derivado 4-aminoalcoxi-1h-benzoimidazoles, composicion farmaceutica que lo contiene y el uso del mismo para la fabricacion de unmedicamento | |
| AR011139A1 (es) | 4-aminoalcoxi-1,3-dihidro-benzoimidazol-2-tionas, su uso en la preparacion de un medicamento y composicion farmaceutica que los contiene |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |